We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+7.21%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.51B
AUM Growth
+$64.9M
Cap. Flow
-$16.6M
Cap. Flow %
-1.1%
Top 10 Hldgs %
48.71%
Holding
135
New
1
Increased
12
Reduced
42
Closed
2

Top Buys

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$1.89M
2
CI icon
Cigna
CI
+$51.7K
3
ESAB icon
ESAB
ESAB
+$40.6K
4
KFRC icon
Kforce
KFRC
+$26.4K
5
YOU icon
Clear Secure
YOU
+$26.3K

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$6.65M
2
PRFT
Perficient Inc
PRFT
+$1.92M
3
AKAM icon
Akamai
AKAM
+$1.45M
4
LMT icon
Lockheed Martin
LMT
+$1.11M
5
TSLA icon
Tesla
TSLA
+$1.05M

Sector Composition

Rank Sector Weight
1 Technology 46.34%
2 Communication Services 16.36%
3 Healthcare 13.41%
4 Consumer Discretionary 11.01%
5 Financials 10.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
26
Cigna
CI
$76.6B
$14.9M 0.99%
44,951
+150
+0.3% +$51.7K
MA icon
27
Mastercard
MA
$477B
$14.5M 0.96%
32,885
– –
ALC icon
28
Alcon
ALC
$33.1B
$14.5M 0.96%
162,760
-668
-0.4% -$57K
MCK icon
29
McKesson
MCK
$98.5B
$14M 0.93%
23,997
-150
-0.6% -$83.5K
AKAM icon
30
Akamai
AKAM
$16.8B
$13.1M 0.87%
145,263
-15,000
-9% -$1.45M
LH icon
31
Labcorp
LH
$24.3B
$12.8M 0.85%
62,707
-609
-1% -$124K
APH icon
32
Amphenol
APH
$188B
$12.5M 0.83%
186,224
– –
QRVO icon
33
Qorvo
QRVO
$7.63B
$11.6M 0.77%
100,007
– –
MCHP icon
34
Microchip Technology
MCHP
$42.8B
$11.3M 0.75%
123,349
– –
REGN icon
35
Regeneron Pharmaceuticals
REGN
$68.8B
$10.3M 0.69%
9,826
– –
GPN icon
36
Global Payments
GPN
$22.1B
$10M 0.66%
103,662
– –
CTSH icon
37
Cognizant
CTSH
$21.5B
$9.96M 0.66%
146,536
-327
-0.2% -$22.2K
DOX icon
38
Amdocs
DOX
$5.53B
$9.84M 0.65%
124,637
-500
-0.4% -$41.1K
CHKP icon
39
Check Point Software Technologies
CHKP
$13.3B
$9.74M 0.65%
59,008
– –
ZBH icon
40
Zimmer Biomet
ZBH
$17.7B
$9.34M 0.62%
86,043
-230
-0.3% -$27.1K
PFE icon
41
Pfizer
PFE
$140B
$8.38M 0.56%
299,470
– –
LMT icon
42
Lockheed Martin
LMT
$134B
$7.01M 0.46%
15,001
-2,400
-14% -$1.11M
AIZ icon
43
Assurant
AIZ
$13.7B
$6.87M 0.46%
41,303
-300
-0.7% -$52K
BNY
44
Bank of New York Mellon
BNY
$108B
$6.42M 0.43%
107,166
-2,383
-2% -$138K
GILD icon
45
Gilead Sciences
GILD
$161B
$5.67M 0.38%
82,681
-902
-1% -$60.2K
INTC icon
46
Intel
INTC
$466B
$5.53M 0.37%
178,476
– –
AIT icon
47
Applied Industrial Technologies
AIT
$12.8B
$4.92M 0.33%
25,372
– –
ISRG icon
48
Intuitive Surgical
ISRG
$121B
$4.76M 0.32%
10,710
-100
-0.9% -$39.8K
CRM icon
49
Salesforce
CRM
$134B
$4.49M 0.3%
17,445
-765
-4% -$205K
CRUS icon
50
Cirrus Logic
CRUS
$6.74B
$4.36M 0.29%
34,176
+134
+0.4% +$14.1K
1
2
3 4 5

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Oak Associates held 135 positions worth $1.51B, up 4.5% from $1.44B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 2.2%. Oak Associates opened 1 new position and exited 2, leaving the 135-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 46% a quarter earlier, followed by Communication Services and Healthcare.

  • Oak Associates's largest Q2 2024 buy was Mercado Libre: 1,200 shares worth $1.97M.
  • Oak Associates added most to Cigna in Q2 2024, an estimated $51.7K increase.
  • Oak Associates's biggest Q2 2024 reduction was KLA, cutting an estimated $6.65M.
  • Oak Associates fully exited Perficient Inc in Q2 2024, selling an estimated $1.92M.
  • Oak Associates's ten largest holdings make up 49% of its $1.51B portfolio in Q2 2024.
  • Oak Associates opened 1 new position and closed 2 in Q2 2024.
  • Oak Associates's portfolio value rose 4.5% quarter-over-quarter to $1.51B.

Based on Oak Associates's 13F filing for Q2 2024, filed 8 Aug 2024.